Significance of Partnership Decisions in Life Sciences Transaction Advisory Services

A life sciences company does not necessarily have to consider independent growth for its future prospects. The issues of collaborating or entering into license agreements and other partnership arrangements are among the aspects that can gain significance during the process.

That is how the demands for advice in connection with transactions involving life sciences are changing. Companies are increasingly looking at the possibility of partnerships in conjunction with conventional financing matters, which creates a new opportunity for transaction advisory services providers.

Partnering decisions can affect the future of a company over a period of years. Possibility to obtain additional expertise or reach of markets can be the reason for making such a decision, and these aspects usually require taking into account various factors beyond finance.

Management teams usually ask for assistance with the evaluation of the potential alternatives even before the negotiations begin. This allows determining whether a certain partnership can be beneficial for the future of the company and what implications will be created by different transaction models.

The complexity of these decisions makes them especially important. A partnering agreement will have an impact on the way the resources are used and the development priorities of a company, so this issue requires proper consultation before negotiating with a counterparty.

Such consulting needs arise in life sciences companies due to the specificity of the industry – scientific programs usually require special expertise and significant investments. In this case, collaboration with another company can give access to this expertise.

Advisory firms providing investment banking solutions are increasingly involved in such discussions. Their role involves analysis of transaction structures, their implications from the strategic point of view, and assistance in comparing different scenarios offered to the management team.

The increased attention paid to the partnership is caused by changes in the whole life sciences sector. Companies are no longer following the same strategies concerning growth; sometimes, collaboration can be the only possible alternative for a certain situation.

The decision-making process becomes especially complicated when several different opportunities occur at the same time. Managers have to weigh different financing alternatives and partnering proposals in light of the strategic goals of their companies.

All this contributes to the emergence of demand for advisory services that go beyond capital raising. The companies usually want to have a structured assessment of the strategic alternatives before making any decision.

The increased significance of partnership discussions means that transaction advisory services in life sciences have become more diverse. Strategic aspects of collaborations are now given much attention along with the usual financial considerations.

In the future, activities in the field will likely reflect this trend.